291 related articles for article (PubMed ID: 19808716)
1. Design of the multicenter standardized supervised exercise training intervention for the claudication: exercise vs endoluminal revascularization (CLEVER) study.
Bronas UG; Hirsch AT; Murphy T; Badenhop D; Collins TC; Ehrman JK; Ershow AG; Lewis B; Treat-Jacobson DJ; Walsh ME; Oldenburg N; Regensteiner JG;
Vasc Med; 2009 Nov; 14(4):313-21. PubMed ID: 19808716
[TBL] [Abstract][Full Text] [Related]
2. The Claudication: Exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods.
Murphy TP; Hirsch AT; Ricotta JJ; Cutlip DE; Mohler E; Regensteiner JG; Comerota AJ; Cohen DJ;
J Vasc Surg; 2008 Jun; 47(6):1356-63. PubMed ID: 18440181
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of endovascular revascularization compared to supervised hospital-based exercise training in patients with intermittent claudication: a randomized controlled trial.
Spronk S; Bosch JL; den Hoed PT; Veen HF; Pattynama PM; Hunink MG
J Vasc Surg; 2008 Dec; 48(6):1472-80. PubMed ID: 18771879
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled trial of supervised exercise to evaluate changes in cardiac function in patients with peripheral atherosclerotic disease.
Hodges LD; Sandercock GR; Das SK; Brodie DA
Clin Physiol Funct Imaging; 2008 Jan; 28(1):32-7. PubMed ID: 18005078
[TBL] [Abstract][Full Text] [Related]
5. The role of exercise training in peripheral arterial disease.
Milani RV; Lavie CJ
Vasc Med; 2007 Nov; 12(4):351-8. PubMed ID: 18048473
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of supervised exercise, stenting, and optimal medical care for claudication: results from the Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) trial.
Reynolds MR; Apruzzese P; Galper BZ; Murphy TP; Hirsch AT; Cutlip DE; Mohler ER; Regensteiner JG; Cohen DJ
J Am Heart Assoc; 2014 Nov; 3(6):e001233. PubMed ID: 25389284
[TBL] [Abstract][Full Text] [Related]
7. Community trial of home-based exercise therapy for intermittent claudication.
Mouser MJ; Zlabek JA; Ford CL; Mathiason MA
Vasc Med; 2009 May; 14(2):103-7. PubMed ID: 19366815
[TBL] [Abstract][Full Text] [Related]
8. Intermittent claudication: cost-effectiveness of revascularization versus exercise therapy.
de Vries SO; Visser K; de Vries JA; Wong JB; Donaldson MC; Hunink MG
Radiology; 2002 Jan; 222(1):25-36. PubMed ID: 11756701
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication.
Treat-Jacobson D; Bronas UG; Leon AS
Vasc Med; 2009 Aug; 14(3):203-13. PubMed ID: 19651669
[TBL] [Abstract][Full Text] [Related]
10. Endovascular intervention for treatment of claudication: is it cost-effective?
O'Brien-Irr MS; Harris LM; Dosluoglu HH; Dryjski ML
Ann Vasc Surg; 2010 Aug; 24(6):833-40. PubMed ID: 20638623
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease.
Jaff MR; Cahill KE; Yu AP; Birnbaum HG; Engelhart LM
Ann Vasc Surg; 2010 Jul; 24(5):577-87. PubMed ID: 20579582
[TBL] [Abstract][Full Text] [Related]
12. Supervised exercise therapy for intermittent claudication in a community-based setting is as effective as clinic-based.
Bendermacher BL; Willigendael EM; Nicolaï SP; Kruidenier LM; Welten RJ; Hendriks E; Prins MH; Teijink JA; de Bie RA
J Vasc Surg; 2007 Jun; 45(6):1192-6. PubMed ID: 17543684
[TBL] [Abstract][Full Text] [Related]
13. The development and implementation of a regional network of physiotherapists for exercise therapy in patients with peripheral arterial disease, a preliminary report.
Willigendael EM; Bendermacher BL; van der Berg C; Welten RJ; Prins MH; Bie de RA; Teijink JA
BMC Health Serv Res; 2005 Jul; 5():49. PubMed ID: 16011806
[TBL] [Abstract][Full Text] [Related]
14. A non-randomised controlled trial of the clinical and cost effectiveness of a Supervised Exercise Programme for claudication.
Lee HL; Mehta T; Ray B; Heng MS; McCollum PT; Chetter IC
Eur J Vasc Endovasc Surg; 2007 Feb; 33(2):202-7. PubMed ID: 17142065
[TBL] [Abstract][Full Text] [Related]
15. Peripheral artery disease: therapeutic advances.
Shamoun F; Sural N; Abela G
Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):539-53. PubMed ID: 18402543
[TBL] [Abstract][Full Text] [Related]
16. The Baltimore activity scale for intermittent claudication: a validation study.
Gardner AW; Montgomery PS
Vasc Endovascular Surg; 2006; 40(5):383-91. PubMed ID: 17038572
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease.
Treesak C; Kasemsup V; Treat-Jacobson D; Nyman JA; Hirsch AT
Vasc Med; 2004 Nov; 9(4):279-85. PubMed ID: 15678620
[TBL] [Abstract][Full Text] [Related]
18. Exercise rehabilitation for patients with peripheral arterial disease.
Regensteiner JG; Hiatt WR
Exerc Sport Sci Rev; 1995; 23():1-24. PubMed ID: 7556347
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of exercise therapy in patients with intermittent claudication: supervised exercise therapy versus a 'go home and walk' advice.
van Asselt AD; Nicolaï SP; Joore MA; Prins MH; Teijink JA;
Eur J Vasc Endovasc Surg; 2011 Jan; 41(1):97-103. PubMed ID: 21159527
[TBL] [Abstract][Full Text] [Related]
20. Supervised exercise training combined with ginkgo biloba treatment for patients with peripheral arterial disease.
Wang J; Zhou S; Bronks R; Graham J; Myers S
Clin Rehabil; 2007 Jul; 21(7):579-86. PubMed ID: 17702699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]